The True Challenges of the Covid-19 Epidemics: The Need for Essential Levels of Care for All

Affiliations

Editorial

Mauro Giovanni Carta et al. Open Respir Med J. 2020.

. 2020 Mar 16:14:8-9.

doi: 10.2174/1874306402014010008. eCollection 2020.

No abstract available

Keywords: Covid19; Epidemics; Essential level of care; Global Health; Public Health.

References

1. Redekop W.K., Mladsi D. The faces of personalized medicine: A framework for understanding its meaning and scope. Value Health. 2013;16(6) Suppl.:S4–S9. doi: 10.1016/j.jval.2013.06.005. - DOI - PubMed
1. Vijverberg S.J.H., Maitland-van der Zee A-H. Priority Medicines for Europe and the World “A Public Health Approach to Innovation”. Background Paper 7.4: Pharmacogenetics and Stratified Medicine. Geneva: World Health Organization; 2013.
1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi: 10.1016/S0140-6736(06)68770-9. - DOI - PubMed
1. Rao M., Ligeiro D., Maeurer M. Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncology. Curr. Opin. Pulm. Med. 2019;25(3):233–241. doi: 10.1097/MCP.0000000000000575. - DOI - PubMed
1. Noah C. Peeri, Nistha Shrestha, Siddikur Rahman, et al. The SARS, MERS and novel Coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? Int. J. Epidemiol. 2020 [Online ahead of print]. - PMC - PubMed